Patel, J.R.; Thangavelu, P.; Terrell, R.M.; Israel, B.; Sarkar, A.B.; Davidson, A.M.; Zhang, K.; Khupse, R.; Tilghman, S.L.
A Novel Allosteric Inhibitor Targets PLK1 in Triple Negative Breast Cancer Cells. Biomolecules 2022, 12, 531.
https://doi.org/10.3390/biom12040531
AMA Style
Patel JR, Thangavelu P, Terrell RM, Israel B, Sarkar AB, Davidson AM, Zhang K, Khupse R, Tilghman SL.
A Novel Allosteric Inhibitor Targets PLK1 in Triple Negative Breast Cancer Cells. Biomolecules. 2022; 12(4):531.
https://doi.org/10.3390/biom12040531
Chicago/Turabian Style
Patel, Jankiben R., Prasad Thangavelu, Renee M. Terrell, Bridg’ette Israel, Arindam Basu Sarkar, A. Michael Davidson, Kun Zhang, Rahul Khupse, and Syreeta L. Tilghman.
2022. "A Novel Allosteric Inhibitor Targets PLK1 in Triple Negative Breast Cancer Cells" Biomolecules 12, no. 4: 531.
https://doi.org/10.3390/biom12040531
APA Style
Patel, J. R., Thangavelu, P., Terrell, R. M., Israel, B., Sarkar, A. B., Davidson, A. M., Zhang, K., Khupse, R., & Tilghman, S. L.
(2022). A Novel Allosteric Inhibitor Targets PLK1 in Triple Negative Breast Cancer Cells. Biomolecules, 12(4), 531.
https://doi.org/10.3390/biom12040531